Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UPL
4251
PUT
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $1.27M | ﹤0.01% |
101,300
-139,300
| -58% | -$2.12M |
|
4252
Icon
ICLR
$12.6B
| $1.27M | ﹤0.01% |
18,820
+8,813
| +88% | +$595K |
|
|
AMED
4253
DELISTED
Amedisys
AMED
| $1.26M | ﹤0.01% |
+31,818
| New | +$991K |
|
4254
Quanex
NX
$819M
| $1.26M | ﹤0.01% |
58,992
-5,635
| -9% | -$109K |
|
|
BEL
4255
DELISTED
Belmond Ltd.
BEL
| $1.26M | ﹤0.01% |
101,221
+32,332
| +47% | +$409K |
|
4256
PUT
Vanda Pharmaceuticals
VNDA
$307M
| $1.26M | ﹤0.01% |
99,500
+97,600
| +5,137% | +$1.05M |
|
|
FCAN
4257
DELISTED
First Trust Canada AlphaDEX Fund
FCAN
| $1.26M | ﹤0.01% |
42,817
+19,902
| +87% | +$619K |
|
4258
CALL
ManpowerGroup
MAN
$2.44B
| $1.26M | ﹤0.01% |
14,100
+1,900
| +16% | +$164K |
|
4259
Nordic American Tanker
NAT
$1.38B
| $1.26M | ﹤0.01% |
89,157
+24,280
| +37% | +$311K |
|
4260
CALL
Autohome
ATHM
$2.67B
| $1.26M | ﹤0.01% |
24,900
+3,700
| +17% | +$182K |
|
4261
Kodak
KODK
$822M
| $1.26M | ﹤0.01% |
74,869
+41,297
| +123% | +$785K |
|
4262
WisdomTree US SmallCap Earnings Fund
EES
$719M
| $1.26M | ﹤0.01% |
44,484
+7,476
| +20% | +$213K |
|
4263
CVR Partners
UAN
$1.36B
| $1.25M | ﹤0.01% |
9,933
+6,755
| +213% | +$924K |
|
|
WNR
4264
PUT
DELISTED
Western Refining Inc
WNR
| $1.25M | ﹤0.01% |
28,700
-6,200
| -18% | -$275K |
|
4265
Telkom Indonesia
TLK
$14.5B
| $1.25M | ﹤0.01% |
57,680
+16,702
| +41% | +$360K |
|
4266
PUT
T. Rowe Price
TROW
$23.9B
| $1.25M | ﹤0.01% |
16,100
+5,400
| +50% | +$436K |
|
|
CTRA
4267
PUT
DELISTED
Coterra Energy
CTRA
| $1.25M | ﹤0.01% |
39,600
-12,800
| -24% | -$427K |
|
4268
iShares Global 100 ETF
IOO
$8.93B
| $1.25M | ﹤0.01% |
33,200
-26,760
| -45% | -$1.06M |
|
|
TGNA
4269
CALL
DELISTED
TEGNA Inc
TGNA
| $1.25M | ﹤0.01% |
60,781
-4,212
| -6% | -$79.3K |
|
4270
W&T Offshore
WTI
$534M
| $1.25M | ﹤0.01% |
227,485
+157,554
| +225% | +$906K |
|
4271
Tennant Co
TNC
$1.43B
| $1.25M | ﹤0.01% |
19,075
+2,403
| +14% | +$157K |
|
4272
Geron
GERN
$828M
| $1.24M | ﹤0.01% |
290,309
+74,626
| +35% | +$296K |
|
4273
Genie Energy
GNE
$367M
| $1.24M | ﹤0.01% |
118,566
-52,166
| -31% | -$593K |
|
|
IMPV
4274
PUT
DELISTED
Imperva, Inc.
IMPV
| $1.24M | ﹤0.01% |
18,300
+5,100
| +39% | +$281K |
|
4275
OneSpan
OSPN
$574M
| $1.24M | ﹤0.01% |
41,000
-13,868
| -25% | -$377K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.